Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters-Reference-Cited by-同舟云学术

Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters

Published:2002-02 Issue:1 Volume:14 Page:15-24
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Lin C-S,Chow S,Lau A,Tu R,Lue T F

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/3900802.pdf

Reference30 articles.

1. Schudt C, Gantner F, Tenors H, Hatzelmann A. . Therapeutic potential of selective PDE inhibitors in asthma. Pulm Pharmacol Ther 1999 12: 123–129.

2. Movsesian MA. . Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate. J Am Coll Cardiol 1999 34: 318–324.

3. Ballard SA et al . Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998 159: 2164–2171.

4. Corbin JD, Francis SH. . Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem 1999 274: 13729–13732.

5. Boolell M et al . Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996 8: 47–52.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting heme in sickle cell disease: new perspectives on priapism treatment;Frontiers in Physiology;2024-07-17

2. Soluble guanylate cyclase stimulators and activators: new horizons in the treatment of priapism associated with sickle cell disease;Frontiers in Pharmacology;2024-02-07

3. Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions;Journal of Pharmacology and Experimental Therapeutics;2024-01-23

4. The effect of red blood cell disorders on male fertility and reproductive health;Nature Reviews Urology;2024-01-03

5. Drug repurposing and structure-based discovery of new PDE4 and PDE5 inhibitors;European Journal of Medicinal Chemistry;2023-12